Elixinol Wellness Limited
EXL.ASXConsumer Staples
Elixinol Wellness Limited is a pioneer in the global hemp industry, innovating, marketing and selling hemp and other plant-derived nutraceutical, cosmetic and food products.
Market Data
$0.008
+0.1%$3.3M
-100000.0x
$-0.022
0.00%
-0.4%
Latest Earnings
FY25 Appendix 4E and Annual Report
27 February 2026
Elixinol Wellness Limited (ASX: EXL) reported FY25 revenue of $15.5M, up 3.6% year-on-year, but net loss deepened sharply to $5.5M from $1.7M in FY24 — a 219.4% increase in losses — driven by integration costs from acquisitions and restructuring charges. The company made progress on its operational reset in H2 FY25, achieving positive underlying operating cash flow in Q4 and a ~30% reduction in operating expenses, though the balance sheet remains stressed with negative net tangible assets. Management is cautiously optimistic about FY26, citing margin improvement, e-commerce growth, and a leaner cost structure, but has not provided specific financial guidance. Key points: Revenue grew 3.6% year-on-year to $15.5M, with Q4 FY25 revenue of $4.1M representing a 9.5% increase on the prior quarter.; Operating expenses reduced by approximately 30% in Q4 FY25 versus the prior corresponding period, creating a structurally leaner organisation.; The Healthy Chef e-commerce sales grew 42% in Q4 FY25 compared to Q4 FY24, demonstrating strong digital channel momentum.
Recent Announcements
FY25 Appendix 4E and Annual Report
Elixinol Wellness Limited (ASX: EXL) reported FY25 revenue of $15.5M, up 3.6% year-on-year, but net loss deepened sharply to $5.5M from $1.7M in FY24 — a 219.4% increase in losses — driven by integration costs from acquisitions and restructuring charges. The company made progress on its operational reset in H2 FY25, achieving positive underlying operating cash flow in Q4 and a ~30% reduction in operating expenses, though the balance sheet remains stressed with negative net tangible assets. Management is cautiously optimistic about FY26, citing margin improvement, e-commerce growth, and a leaner cost structure, but has not provided specific financial guidance. Key points: Revenue grew 3.6% year-on-year to $15.5M, with Q4 FY25 revenue of $4.1M representing a 9.5% increase on the prior quarter.; Operating expenses reduced by approximately 30% in Q4 FY25 versus the prior corresponding period, creating a structurally leaner organisation.; The Healthy Chef e-commerce sales grew 42% in Q4 FY25 compared to Q4 FY24, demonstrating strong digital channel momentum.
EXL Updated Investor Presentation - Q4FY25 Results & Outlook
Elixinol Wellness (ASX:EXL) reported Q4 FY25 revenue of $4.1M (up 9.5% QoQ) with full year revenue of $15.5M (up 3.6% YoY). The company achieved underlying operating cash flow positive for the quarter and reduced operating costs by approximately 30% compared to Q4 FY24, positioning for profitability with a solid foundation for growth and M&A opportunities. Key points: Q4 revenue of $4.1M up 9.5% quarter-on-quarter with seasonally strong performance; Underlying operating cash flow positive for the quarter; 30% reduction in operating cost base in Q4 FY25 vs Q4 FY24
Q4 FY25 Results & Outlook - Notification of Webinar
This is a notification announcement for Elixinol Wellness Ltd's upcoming Q4 FY25 results webinar scheduled for February 12, 2026. No financial results or metrics are disclosed in this announcement, as it only provides webinar registration details. Actual results and outlook will be presented during the webinar. Key points: Management will provide comprehensive overview of Q4 FY25 results and outlook; Interactive Q&A session planned for investor engagement; Company operates vertically integrated business across Australia and USA
Get real-time alerts for EXL
Receive AI-powered earnings summaries and instant notifications when Elixinol Wellness Limited releases results.
Register Free